RED VIOLET INC (RDVT)

US75704L1044 - Common Stock

17.37  +0.36 (+2.12%)

Fundamental Rating

6

Overall RDVT gets a fundamental rating of 6 out of 10. We evaluated RDVT against 276 industry peers in the Software industry. RDVT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. RDVT is not valued too expensively and it also shows a decent growth rate.



6

1. Profitability

1.1 Basic Checks

RDVT had positive earnings in the past year.
RDVT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RDVT reported negative net income in multiple years.
RDVT had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

RDVT has a Return On Assets of 14.56%. This is amongst the best in the industry. RDVT outperforms 93.80% of its industry peers.
RDVT's Return On Equity of 15.72% is amongst the best of the industry. RDVT outperforms 87.96% of its industry peers.
RDVT has a Return On Invested Capital of 2.44%. This is in the better half of the industry: RDVT outperforms 74.09% of its industry peers.
Industry RankSector Rank
ROA 14.56%
ROE 15.72%
ROIC 2.44%
ROA(3y)5.41%
ROA(5y)-3.91%
ROE(3y)5.84%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 22.49%, RDVT belongs to the top of the industry, outperforming 91.97% of the companies in the same industry.
RDVT's Operating Margin of 4.16% is fine compared to the rest of the industry. RDVT outperforms 72.63% of its industry peers.
The Gross Margin of RDVT (78.28%) is better than 77.74% of its industry peers.
In the last couple of years the Gross Margin of RDVT has grown nicely.
Industry RankSector Rank
OM 4.16%
PM (TTM) 22.49%
GM 78.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y10.75%

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RDVT is destroying value.
Compared to 1 year ago, RDVT has about the same amount of shares outstanding.
RDVT has more shares outstanding than it did 5 years ago.
RDVT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

RDVT has an Altman-Z score of 21.79. This indicates that RDVT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 21.79, RDVT belongs to the best of the industry, outperforming 97.45% of the companies in the same industry.
RDVT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.79
ROIC/WACC0.25
WACC9.93%

2.3 Liquidity

A Current Ratio of 8.26 indicates that RDVT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 8.26, RDVT belongs to the top of the industry, outperforming 94.53% of the companies in the same industry.
RDVT has a Quick Ratio of 8.26. This indicates that RDVT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 8.26, RDVT belongs to the top of the industry, outperforming 94.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.26
Quick Ratio 8.26

4

3. Growth

3.1 Past

RDVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2500.00%, which is quite impressive.
The Revenue has grown by 12.92% in the past year. This is quite good.
Measured over the past years, RDVT shows a very strong growth in Revenue. The Revenue has been growing by 29.86% on average per year.
EPS 1Y (TTM)2500%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q116.67%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y20.29%
Revenue growth 5Y29.86%
Revenue growth Q2Q15.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

RDVT is valuated correctly with a Price/Earnings ratio of 16.70.
Compared to the rest of the industry, the Price/Earnings ratio of RDVT indicates a rather cheap valuation: RDVT is cheaper than 89.05% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 24.55, RDVT is valued a bit cheaper.
Industry RankSector Rank
PE 16.7
Fwd PE N/A

4.2 Price Multiples

85.77% of the companies in the same industry are more expensive than RDVT, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RDVT indicates a somewhat cheap valuation: RDVT is cheaper than 66.42% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 40.93
EV/EBITDA 18.92

4.3 Compensation for Growth

The decent profitability rating of RDVT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RDVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RED VIOLET INC

NASDAQ:RDVT (5/2/2024, 2:29:58 PM)

17.37

+0.36 (+2.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap242.49M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.7
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.56%
ROE 15.72%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.16%
PM (TTM) 22.49%
GM 78.28%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 8.26
Quick Ratio 8.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)2500%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.92%
Revenue growth 3Y20.29%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y